2004
DOI: 10.1016/j.iac.2004.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Role of tumor necrosis factor alpha in asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
25
0
2

Year Published

2006
2006
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(27 citation statements)
references
References 81 publications
0
25
0
2
Order By: Relevance
“…In the model shown in figure 1, Th2 cytokines play a key role in amplifying the tissue-specific features of asthma, such as goblet cell hyperplasia and transformation of fibroblasts to myofibroblasts. Placing airway tissue-specific events at the centre of asthma pathogenesis provides an explanation for the incomplete effectiveness of inhaled corticosteroids and the therapeutic synergy observed between inhaled corticosteroids and long-acting b 2 -adrenoceptor agonists, the relatively poor correlation of submucosal eosinophil numbers with disease activity or chronicity, the presence of ''remodelling'' changes in the airways at the inception of asthma in the relative absence of eosinophils, the occurrence of asthma in the absence of atopy (as is prominent in occupational and aspirin-intolerant asthma) and the recently discovered efficacy of anti-TNF-a observed in patients with severe corticosteroid-dependent disease [24]. A key role of epithelial-mesenchymal communication in asthma is further endorsed by the observation that six of the seven asthma susceptibility genes discovered by positional cloning are localised to the EMTU, stating this in the form of the following hypothesis.…”
Section: Epithelial Mesenchymal Communicationmentioning
confidence: 99%
“…In the model shown in figure 1, Th2 cytokines play a key role in amplifying the tissue-specific features of asthma, such as goblet cell hyperplasia and transformation of fibroblasts to myofibroblasts. Placing airway tissue-specific events at the centre of asthma pathogenesis provides an explanation for the incomplete effectiveness of inhaled corticosteroids and the therapeutic synergy observed between inhaled corticosteroids and long-acting b 2 -adrenoceptor agonists, the relatively poor correlation of submucosal eosinophil numbers with disease activity or chronicity, the presence of ''remodelling'' changes in the airways at the inception of asthma in the relative absence of eosinophils, the occurrence of asthma in the absence of atopy (as is prominent in occupational and aspirin-intolerant asthma) and the recently discovered efficacy of anti-TNF-a observed in patients with severe corticosteroid-dependent disease [24]. A key role of epithelial-mesenchymal communication in asthma is further endorsed by the observation that six of the seven asthma susceptibility genes discovered by positional cloning are localised to the EMTU, stating this in the form of the following hypothesis.…”
Section: Epithelial Mesenchymal Communicationmentioning
confidence: 99%
“…The proinflammatory activities of TNF-α including leukocyte recruitment through the upregulation of adhesion molecules on endothelial cells and induction of cytokine and chemokine synthesis seem involved in the pathogenesis of asthma [76]. Elevated levels of TNF-α have been detected in bronchoalveolar lavage fluid and biopsy samples in asthmatic patients [77].…”
Section: Proinflammatory Cytokines In the Allergic Inflammationmentioning
confidence: 99%
“…1,2 In human beings, TNF can induce lung neutrophil infiltration and increase airway hyperreactivity (AHR) to methacholine in normal individuals 3 ; some patients with asthma exhibit elevated serum TNF 4 ; TNF immunoreactive cells (mostly mast cells) were ;6-fold increased in airway submucosa biopsies of patients with asthma versus normal controls 5 ; and anti-TNF therapy reduced asthma severity in some subjects. [6][7][8][9][10] However, experiments in TNF-deficient or TNF receptor (TNFR)-deficient mice have not fully clarified the role of TNF in pulmonary allergic inflammation, or the associated AHR, in mice. In BALB/c mice sensitized with ovalbumin (OVA) without aluminum hydroxide (alum), treatment with anti-TNF neutralizing antibodies did not significantly reduce either AHR or numbers of bronchoalveolar lavage fluid (BALF) eosinophils after OVA challenge.…”
mentioning
confidence: 99%